Latest overall cancer Stories
Daily aspirin usage is associated with lower overall cancer mortality, but the association may be smaller than what was previously believed.
A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical guidelines for the use of aspirin in preventative care.
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective.
Long-term use of statins is unlikely to substantially increase or decrease overall cancer risk, but was associated with lowering risk of melanoma, endometrial cancer and non-Hodgkin lymphoma.
Researchers have further established that long-term use of statins is unlikely to substantially increase or decrease overall cancer risk.
A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy.